Interest Pushes Humira Award Up To $1.85B

By Brendan Pierson

Law360, New York (December 18, 2009, 4:30 PM ET) -- A federal judge has ordered Abbott Laboratories to pay Centocor Ortho Biotech Inc. interest of nearly $176 million on the record $1.67 billion judgment he awarded the Johnson & Johnson unit after a jury found that Abbott's arthritis drug Humira infringed a Centocor patent.

In a final judgment entered Friday in the U.S. District Court for the Eastern District of Texas, Judge T. John Ward said he calculated the interest beginning on the date the patent-in-suit was issued, July 4, 2006, using the average 90-day commercial...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles